Behçet Syndrome 2019
DOI: 10.1007/978-3-030-24131-5_19
|View full text |Cite
|
Sign up to set email alerts
|

Disease Assessment in Behçet Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 53 publications
1
8
0
Order By: Relevance
“…More aggressive treatments could be considered for mucocutaneous activity that could not be eliminated by non-IS medications in a limited period. 2,[11][12][13][14] These results were in accordance with the previous studies reporting that BS patients with systemic involvement were preceded by mucocutaneous manifestations, especially in younger patients. 40,41 Second, we addressed the moderational effect of age on mucocutaneous manifestations in BS.…”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations
“…More aggressive treatments could be considered for mucocutaneous activity that could not be eliminated by non-IS medications in a limited period. 2,[11][12][13][14] These results were in accordance with the previous studies reporting that BS patients with systemic involvement were preceded by mucocutaneous manifestations, especially in younger patients. 40,41 Second, we addressed the moderational effect of age on mucocutaneous manifestations in BS.…”
Section: Discussionsupporting
confidence: 90%
“…Therefore, user‐friendly, patient‐driven activity indices are valuable tools to measure clinical progress from the BS patient’s perspective. Yet, “what to measure” and “how to measure” are critical points owing to the diversity of organ involvement in BS 4,7–11,27–31 …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In fact, several systems for measurement (both scores and indexes) of patient-reported outcomes exist to better manage Behcet’s syndrome, some validate as disease-specific (Total Activity Index, Behcet’s Disease Current Activity Form, Behcet’s Syndrome Activity Scale) and other as organ-specific (Oral Ulcer Severity Score, Genital Ulcer Severity Score, Composite Index for oral ulcers and Muco-cutaneous Index) [ 72 , 73 ]. Overall, occurrence of mucocutaneous lesions (which is classically in women and decrease with advancing age) with musculoskeletal involvement represents the milder manifestation of the disease; oral ulcer activity, which is usually persistent especially in young male, and frequently precedes other organ involvement [ 66 , 67 , 68 , 72 , 73 , 74 ].…”
Section: Autoimmune and Disimmune Diseasesmentioning
confidence: 99%